NCT07012057: A trial that was reported late by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT07012057 |
|---|---|
| Title | A Phase II Open-Label Study of Deucravacitinib for Refractory Adults With Dermatomyositis/ Juvenile Dermatomyositis |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 26, 2025 |
| Completion date | March 30, 2028 |
| Required reporting date | March 30, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Nov. 25, 2025 |
| Days late | None |